Biocartis Announces Market Release of SeptiCyte® RAPID test on Idylla™
Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces the market release
How is Cell Isolation Revolutionizing Medical Industry?
One of the biggest medical advancements of recent times is the invention of the cell isolation method. Also known as
Full CPhI & Pharmapack Europe schedule returns in 2021 with live & hybrid events
Informa Markets announces its complete listing of pharma event dates for 2021 at the opening of the first CPhI Festival
Syntegon goes live at PACK EXPO Connects 2020
Since the in-person PACK EXPO International and Healthcare Packaging EXPO have been cancelled, the process and packaging technology specialist Syntegon
Biocartis Receives EUR 1.2 million Grant for Development of Highly Innovative Idylla™ GeneFusion Assay
Biocartis Group NV (the ‘Company’ or ‘Biocartis’), an innovative molecular diagnostics company (Euronext Brussels: BCART), today announces that it has
6 Reasons Why Ranitidine Is Harmful and How It Caused Cancer to Many
Ranitidine is a pharmaceutical drug that is categorized as a histamine antagonist, also called an H2 blocker, that has popularly